Making best practice, everyday practice

Login Register

Looking ahead – The International Diabetes and Cardiovascular Summit, Moscow

Intensification of diabetes treatment with fixed-ratio therapy in the form of a combination of glargine 300 and lixisenatide shows improvement of HbA1c relative to instituting therapy sequentially or using basal-bolus regimens.

Do you like this? Share with a colleague